Item | Control group (n = 29) | Intervention group (n = 31) | p-Value | |
---|---|---|---|---|
Patient characteristics | Gender (female, %) | 17 (58.6%) | 19 (61.3%) | 1.000 |
Living situation (home-cared, %) | 22 (75%) | 20 (64.5%) | 0.4051 | |
Age (mean, SD, range; years) | 79.5 ± 8.62 (66–99) | 75.9 ± 6.87 (66–91) | 0.0856 | |
Length of stay on ward (mean, SD, range; days) | 10.1 ± 6.0 (3–29) | 11.9 ± 8.5 (4–40) | 0.0671 | |
Number of drugs during hospital stay (mean, SD, range) | 16.3 ± 6.3 (7–32) | 17.3 ± 7.3 (6–40) | 0.5649 | |
Drug-related readmissions (DRRs) | Number | 7 | 6 | |
Number of patients with DRR | 7 | 3 | ||
Adverse drug reactions (ADRs) during follow-up | Number | 14 | 21 | |
Number of preventable/ameliorable ADR (NCC-MERP category F-H) regarded as “preventable DRR” | 4 | 1 | ||
Number of preventable/ameliorable ADR (NCC-MERP category D-E) | 2 | 7 | ||
Adverse drug reactions (ADRs) during hospital stay | Number | 9 | 9 | |
Potential inappropriate medication (PIM) | One-year prevalence of PIM | 20 | 31 | |
Changes in medication after discharge during follow-up | Number per patient | 16 ± 11 (3–47) | 16 ± 10 (3–52) |